InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the full record of transactions filed by Mccann Joe A., 董事长兼首席执行官. Insider active across 1 company, notably POINT Biopharma Global Inc.. Cumulatively, 4 filings have been recorded. Breakdown: 1 buy · 0 sell. Total volume traded: €14k. Activity tracked since 29 November 2022. The latest transaction was disclosed on 6 November 2023 (Don). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Joe A. McCann is the Chief Executive Officer of POINT Biopharma Global Inc. He leads the company in the biopharmaceutical sector, focusing on the development of targeted treatments for cancer. With extensive experience in the industry, Joe A. McCann is responsible for the overall strategy and operational direction of the company.